SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-025453
Filing Date
2018-04-18
Accepted
2018-04-18 18:40:36
Documents
2
Period of Report
2018-04-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4161
2 POA DOCUMENT poa.txt EX-24.4_784349 3558
  Complete submission text file 0001209191-18-025453.txt   9061
Mailing Address C/O ARBUTUS BIOPHARMA CORP. 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address
KARBE FRANK (Reporting) CIK: 0001276700 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37929 | Film No.: 18762198

Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS (441) 824-8101
Myovant Sciences Ltd. (Issuer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations